‘Forever chemicals’ in tap water linked to earlier deaths in prostate cancer patients - report
Higher estimated exposure to certain “forever chemicals” in drinking water was linked to a greater risk of death among men diagnosed with prostate cancer, a new US study found.
Posted on medRxiv on November 12, the preprint has yet to undergo peer review.
PFAS, short for per- and polyfluoroalkyl substances, are chemicals used in products that resist heat, oil and water, including firefighting foams, waterproof clothing and nonstick cookware.
Some persist in the environment for long periods, earning them the name “forever chemicals.” Drinking water can be a significant source of exposure where supplies are contaminated.
Lead author Hari S. Iyer works at Rutgers Cancer Institute, where his research focuses on environmental exposures and prostate cancer outcomes.
What the researchers found
The team followed 51,289 New Jersey men diagnosed between 2006 and 2017 through 2024. It linked residential histories to estimated PFAS levels in 566 community water systems. During follow-up, 19,749 men died, including 3,778 from prostate cancer and 4,972 from cardiovascular disease.
Results varied by chemical and analysis. Associations were stronger when researchers examined exposure estimates from five years earlier. In those models, the highest PFOA and PFOS exposure groups had 15% and 16% higher mortality hazards from all causes, respectively, than the lowest groups. The models accounted for demographic, clinical, and neighborhood factors.
A mortality hazard measures the rate at which deaths occur during follow-up. A relative increase alone cannot tell an individual patient how much their absolute chance of dying would change.
Exposure estimates reflected local water supplies, leaving uncertainty about each man’s actual intake. The observational findings cannot establish causation. The authors said confirmation in other studies was needed.
What is known about PFAS and cancer
The International Agency for Research on Cancer classified PFOA as carcinogenic to humans in 2023 and PFOS as possibly carcinogenic to humans. Such classifications identify a cancer hazard; the risk to an individual also depends on exposure.
Evidence concerning prostate cancer has been mixed. The US National Cancer Institute describes an earlier study of 750 aggressive prostate cancer cases and 750 comparison participants that found no association between higher blood levels of the PFAS studied and aggressive prostate cancer risk.
Developing cancer and surviving after a diagnosis are separate research questions, so findings on one do not settle the other.
For people concerned about their drinking water, the US Environmental Protection Agency recommends contacting the local water supplier to ask about PFAS testing and results. Filters certified to reduce PFAS can lower exposure, although effectiveness depends on the filter and proper maintenance.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.